Παρακολούθηση
Alan Brennan
Alan Brennan
University of Sheffield
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα sheffield.ac.uk - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
A taxonomy of model structures for economic evaluation of health technologies
A Brennan, SE Chick, R Davies
Health economics 15 (12), 1295-1310, 2006
6512006
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4
J Karnon, J Stahl, A Brennan, JJ Caro, J Mar, J Möller
Medical decision making 32 (5), 701-711, 2012
6102012
Screening for type 2 diabetes: literature review and economic modelling
N Waugh, G Scotland, P McNamee, M Gillett, A Brennan, E Goyder, ...
HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 11 (17), 2007
4242007
Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study
J Holmes, Y Meng, PS Meier, A Brennan, C Angus, A Campbell-Burton, ...
The Lancet 383 (9929), 1655-1664, 2014
4102014
Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model
RC Purshouse, PS Meier, A Brennan, KB Taylor, R Rafia
The Lancet 375 (9723), 1355-1364, 2010
3432010
Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach
M Strong, JE Oakley, A Brennan
Medical Decision Making 34 (3), 311-326, 2014
2912014
Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness …
M Gillett, HM Dallosso, S Dixon, A Brennan, ME Carey, MJ Campbell, ...
Bmj 341, 2010
2762010
Accurate, practical and cost-effective assessment of carotid stenosis in the UK.
JM Wardlaw, FM Chappell, M Stevenson, E De Nigris, S Thomas, J Gillard, ...
Health Technology Assessment (Winchester, England) 10 (30), iii-iv, ix, 2006
2742006
Policy options for alcohol price regulation: the importance of modelling population heterogeneity
PS Meier, R Purshouse, A Brennan
Addiction 105 (3), 383-393, 2010
2552010
Modelling in health economic evaluation: What is its place? What is its value?
A Brennan, R Akehurst
Pharmacoeconomics 17, 445-459, 2000
2342000
Should patients have a greater role in valuing health states?
J Brazier, R Akehurst, A Brennan, P Dolan, K Claxton, C McCabe, ...
Applied health economics and health policy 4, 201-208, 2005
2162005
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation
M Gillett, P Royle, A Snaith, G Scotland, AS Poobalan, M Imamura, ...
Health technology assessment 16 (33), 2012
2152012
Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK
A Brennan, N Bansback, A Reynolds, P Conway
Rheumatology 43 (1), 62-72, 2004
2092004
Estimated effects of different alcohol taxation and price policies on health inequalities: a mathematical modelling study
PS Meier, J Holmes, C Angus, AK Ally, Y Meng, A Brennan
PLoS medicine 13 (2), e1001963, 2016
1942016
Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
A Pandor, P Thokala, T Gomersall, H Baalbaki, JW Stevens, J Wang, ...
Health Technology Assessment (Winchester, England) 17 (32), 1, 2013
1932013
Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis
RM Nixon, N Bansback, A Brennan
Statistics in medicine 26 (6), 1237-1254, 2007
1862007
Trend analysis and modelling of gender‐specific age, period and birth cohort effects on alcohol abstention and consumption level for drinkers in G reat B ritain using the G …
Y Meng, J Holmes, D Hill‐McManus, A Brennan, PS Meier
Addiction 109 (2), 206-215, 2014
1612014
Calculating partial expected value of perfect information via Monte Carlo sampling algorithms
A Brennan, S Kharroubi, A O'hagan, J Chilcott
Medical Decision Making 27 (4), 448-470, 2007
1592007
Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
NJ Bansback, A Brennan, O Ghatnekar
Annals of the rheumatic diseases 64 (7), 995-1002, 2005
1592005
Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
A Brennan, N Bansback, R Nixon, J Madan, M Harrison, K Watson, ...
Rheumatology 46 (8), 1345-1354, 2007
1452007
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20